Capsule is a healthcare technology business rebuilding the pharmacy from the inside out.
Capsule delivers prescription drugs to local patients in two hours via an online app, said it is in the process of applying for pharmacy licenses in additional states.
Capsule was founded in 2016 by Eric Kinariwala and is based in New York, New York.
Capsule's platform utilizes artificial intelligence and real-world data from the operating room to provide actionable insights to the care team. It can also connect surgeons with outside experts, such as medical school instructors or medical device representatives, in real-time.
Capsule is rebuilding the $425 billion pharmacy industry from the inside out with an emotionally resonant brand and technology that enables customized outcomes for doctors, hospitals, insurers, and manufacturers.
Capsule's software also has features to make prescribing easier for doctors, allowing them to set up refill preferences and specify alternate drugs if a patient’s insurance won’t cover the first choice. The company has 60,000 customers in New York, most on multiple medications.
Capsule is backed by TCV, Thrive Capital, Durable Capital Partners LP, Baillie Gifford & Co., T Rowe Price Group Inc., and others. The company raised $300M in Series D round on Apr 28, 2021. This brings Capsule's total funding to $570M to date. The latest round valued Capsule at $1B post-money.